Alzheimer’s disease is the most common cause of dementia and currently affects more than 6 million Americans and at least 50 million people worldwide. Despite decades of research and over 400 clinical trials, no drug has been found to cure or significantly modify the course of the disease. Perhaps the biggest reason for this is that Alzheimer’s and other neurodegenerative conditions are triggered by many different factors and no medication or individual treatment can target the variety of root causes at work. Imagine working as a mechanic and trying to fix every broken car that comes to your shop by repairing one thing!
Alzheimer’s disease is characterized by a buildup of amyloid beta protein plaques and neurofibrillary tangles made of tau protein. The buildup of tangles and plaques often begins 10 to 20 years before symptoms of memory loss, language impairment, trouble planning and reasoning, disorientation, and other symptoms show up.
Fortunately, many brilliant researchers and physicians agree that a personalized, multi-interventional approach that addresses individual specific challenges can strengthen brain health and support cognition. When the brain is injured, or when neurological needs are unsupported, cognition can be impaired and neurodegenerative disease can progress. However, when various triggers or risks of cognitive disorders are identified and optimized, cognition and brain health can improve.
In lieu of a pre-determined, single pharmaceutical drug treatment for neurological dysfunction, individuals can be screened for several neurodegenerative contributors. These can include, but are not limited to nutrient and hormone deficiencies, inflammation, insulin resistance and diabetes, pathogens and biotoxins, chemicals and organic toxins, compromised blood flow, disordered lifestyles, dental decay, chronic infection, and a host of other variables. When contributors are identified, at-risk individuals can adopt a personalized, therapeutic protocol that offers real hope for improvement.